Fighting liver cancer takes big financial toll: Study
Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.
Feb 2, 2023
0
9
Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.
Feb 2, 2023
0
9
Most people don't think about their blood type unless they need surgery or are planning to donate blood. But we can learn more from our blood types than simply whether or not we can safely accept a transfusion from a donor. ...
Jan 25, 2023
0
11
Cancer cells have developed multiple mechanisms to thrive. One example, derived from age-old theories of evolution, is positive selection i.e., the propensity of cells with favorable cancer mutations to flourish. However, ...
Jan 18, 2023
0
12
A new research paper titled "Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001" has been published in Oncotarget.
Jan 17, 2023
0
29
CAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood cancers, may enhance the effectiveness of surgery for solid tumors, according to a preclinical study from researchers in the ...
Jan 11, 2023
0
71
Only 14% of cancers diagnosed in the United States are diagnosed after the patient had a recommended screening test, according to a report released Dec. 14 by NORC at the University of Chicago.
Dec 28, 2022
0
36
The great hope of cancer immunotherapy is to bolster our own immune cells in specific ways to keep cancer cells from evading our immune system. Although much progress has been made, immunotherapy does not always work well. ...
Dec 19, 2022
0
39
A team at Memorial Sloan Kettering Cancer Center (MSK) has uncovered several mechanisms of immune escape that can help explain why ovarian cancers have been resistant to immunotherapy to date.
Dec 15, 2022
0
52
Cancer is one of the deadliest diseases in the world and is more difficult to cure when detected at a late stage.
Dec 7, 2022
0
71
A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models ...
Dec 6, 2022
0
11